Barinthus Biotherapeutics plc. (BRNS)

Latest Insider Confidence Score

2025Q4

50.0
Bullish

Company insider confidence (by quarter)

2021Q2 2025Q4

Largest shareholders

Insider Role (last 12 mo) Shares held Filed at
M&G Alternatives Investment Management Ltd — 4,108,752 Nov 5, 2021
Oxford Science Enterprises plc 10% Owner 1,661,184 May 6, 2021
M&G Investment Management Ltd 10% Owner 963,597 May 3, 2021
Lynn Geoffrey — 640,639 Dec 31, 2024
Enright William CEO 443,981 Jan 4, 2024

Recent buy/sell transactions

Exec date Filing date Insider Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Jun 10, 2025 Jun 11, 2025 Hammacher Alex Director Neutral 52.5 - 0.00% ✗ -
Jun 10, 2025 Jun 11, 2025 Wright Robin Director Neutral 52.5 - 0.00% ✗ -
Jun 10, 2025 Jun 11, 2025 Morgon Pierre A. Director Neutral 52.5 - 0.00% ✗ -
Jun 10, 2025 Jun 11, 2025 Phillips Anne M. Director Neutral 52.5 - 0.00% ✗ -
Jun 10, 2025 Jun 11, 2025 Scheeren Joseph Director Neutral 52.5 - 0.00% ✗ -
Jun 10, 2025 Jun 11, 2025 DAWES KAREN A Director Neutral 52.5 - 0.00% ✗ -
Feb 3, 2025 Feb 5, 2025 Brown Gemma CFO Neutral 52.5 - 0.00% ✗ -
Feb 3, 2025 Feb 5, 2025 Enright William CEO Neutral 52.5 - 0.00% ✗ -
Feb 3, 2025 Feb 5, 2025 Griffiths Graham Chief Business Officer Neutral 52.5 - 0.00% ✗ -
Feb 3, 2025 Feb 5, 2025 Hooftman Leon Chief Medical Officer Neutral 52.5 - 0.00% ✗ -
Dec 31, 2024 Lynn Geoffrey Chief Scientific Officer Neutral 52.5 - 0.00% ✗ -
Dec 20, 2024 Lynn Geoffrey Chief Scientific Officer Neutral 52.5 - 0.00% ✗ -
Jun 3, 2024 Jun 18, 2024 Hooftman Leon Chief Medical Officer Neutral 52.5 - 0.00% ✗ -
Jun 18, 2024 Hooftman Leon Chief Medical Officer Neutral 52.5 - 0.00% ✗ -
May 10, 2024 May 14, 2024 DAWES KAREN A Director Neutral 52.5 - 0.00% ✗ -
May 10, 2024 May 14, 2024 Scheeren Joseph Director Neutral 52.5 - 0.00% ✗ -
May 10, 2024 May 14, 2024 Phillips Anne M. Director Neutral 52.5 - 0.00% ✗ -
May 10, 2024 May 14, 2024 Hammacher Alex Director Neutral 52.5 - 0.00% ✗ -
May 10, 2024 May 14, 2024 Morgon Pierre A. Director Neutral 52.5 - 0.00% ✗ -
May 10, 2024 May 14, 2024 Wright Robin Director Neutral 52.5 - 0.00% ✗ -
Jan 2, 2024 Jan 4, 2024 Pelletier Nadege Chief Scientific Officer Neutral 52.5 - 0.00% ✗ -
Jan 2, 2024 Jan 4, 2024 Griffiths Graham Chief Business Officer Neutral 52.5 - 0.00% ✗ -
Jan 2, 2024 Jan 4, 2024 Enright William CEO Neutral 52.5 - 0.00% ✗ -
Jan 2, 2024 Jan 4, 2024 Brown Gemma CFO Neutral 52.5 - 0.00% ✗ -
Jun 26, 2023 Jun 28, 2023 Scheeren Joseph Director Buy 91.3 +10,000 76.92% ✗ $24.4K
May 25, 2023 Jun 1, 2023 Wright Robin Director Buy 91.3 +13,750 39.85% ✗ $36.6K
May 11, 2023 May 12, 2023 Wright Robin Director Neutral 52.5 - 0.00% ✗ -
May 11, 2023 May 12, 2023 Scheeren Joseph Director Neutral 52.5 - 0.00% ✗ -
May 11, 2023 May 12, 2023 Phillips Anne M. Director Neutral 52.5 - 0.00% ✗ -
May 11, 2023 May 12, 2023 Morgon Pierre A. Director Neutral 52.5 - 0.00% ✗ -
May 11, 2023 May 12, 2023 Hammacher Alex Director Neutral 52.5 - 0.00% ✗ -
May 11, 2023 May 12, 2023 DAWES KAREN A Director Neutral 52.5 - 0.00% ✗ -
Jan 3, 2023 Mar 29, 2023 Marshall Margaret Chief Medical Officer Neutral 52.5 - 0.00% ✗ -
Jan 3, 2023 Mar 29, 2023 Evans Thomas George Fmr Chief Scientific Officer Neutral 52.5 - 0.00% ✗ -
Mar 27, 2023 Mar 29, 2023 Enright William CEO Sell 26.3 -15,000 -2.02% ✗ $36.3K
Feb 1, 2023 Feb 24, 2023 Pelletier Nadege Chief Scientific Officer Neutral 52.5 - 0.00% ✗ -
Feb 24, 2023 Pelletier Nadege Chief Scientific Officer Neutral 52.5 - 0.00% ✗ -
Jan 3, 2023 Feb 23, 2023 Griffiths Graham Chief Business Officer Neutral 52.5 - 0.00% ✗ -
Jan 3, 2023 Feb 23, 2023 Enright William CEO Neutral 52.5 - 0.00% ✗ -
Jan 3, 2023 Feb 23, 2023 Ellis Christopher COO Neutral 52.5 - 0.00% ✗ -
Jan 3, 2023 Feb 23, 2023 Brown Gemma CFO Neutral 52.5 - 0.00% ✗ -
Jun 15, 2022 Feb 10, 2023 Wright Robin Director Neutral 52.5 - 0.00% ✗ -
Jun 15, 2022 Feb 10, 2023 Scheeren Joseph Director Neutral 52.5 - 0.00% ✗ -
Jun 15, 2022 Feb 10, 2023 Phillips Anne M. Director Neutral 52.5 - 0.00% ✗ -
Jun 15, 2022 Feb 10, 2023 Morgon Pierre A. Director Neutral 52.5 - 0.00% ✗ -
Jun 15, 2022 Feb 10, 2023 Hammacher Alex Director Neutral 52.5 - 0.00% ✗ -
Jun 15, 2022 Feb 10, 2023 DAWES KAREN A Director Neutral 52.5 - 0.00% ✗ -
Sep 30, 2022 Oct 4, 2022 M&G Alternatives Investment Management Ltd 10% Owner Neutral 27.5 -4,108,752 -100.00% ✗ -
Sep 30, 2022 Oct 4, 2022 M&G INVESTMENT MANAGEMENT LTD 10% Owner Neutral 90.0 +4,108,752 377.44% ✗ -
Sep 26, 2022 Sep 28, 2022 Brown Gemma CFO Neutral 52.5 - 0.00% ✗ -
Sep 23, 2022 Brown Gemma CFO Neutral 52.5 - 0.00% ✗ -
Aug 25, 2022 Aug 26, 2022 Griffiths Graham Chief Business Officer Sell 22.5 -10,000 -8.76% ✗ $73.9K
Aug 24, 2022 Aug 26, 2022 Ellis Christopher COO Sell 20.0 -39,626 -61.10% ✗ $259.5K
Aug 17, 2022 Aug 19, 2022 Ellis Christopher COO Sell 26.3 -2,824 -94.96% ✗ $13.6K
Aug 17, 2022 Aug 19, 2022 Griffiths Graham Chief Business Officer Sell 45.0 -500 -0.44% ✗ $2.4K
Aug 15, 2022 Aug 17, 2022 Ellis Christopher COO Sell 26.3 -7,550 -98.05% ✗ $36K
Aug 15, 2022 Aug 17, 2022 Griffiths Graham Chief Business Officer Sell 26.3 -3,620 -3.06% ✗ $17.3K
Aug 12, 2022 Aug 15, 2022 Griffiths Graham Chief Business Officer Sell 26.3 -5,000 -4.05% ✗ $22.5K
Jun 28, 2022 Jul 15, 2022 Ellis Christopher COO Sell 27.5 -5 -6.25% ✗ $30
Jun 23, 2022 Jul 15, 2022 Griffiths Graham Chief Business Officer Buy 55.0 +92 0.07% ✗ $544.6
Apr 1, 2022 Apr 4, 2022 Scheeren Joseph Director Buy 95.0 +10,000 333.33% ✗ $50.9K
Mar 31, 2022 Apr 4, 2022 Hammacher Alex Director Buy 91.3 +2,000 200.00% ✗ $10.3K
Dec 17, 2021 Feb 11, 2022 Griffiths Graham Chief Business Officer Neutral 52.5 - 0.00% ✗ -
Jan 3, 2022 Feb 11, 2022 Marshall Margaret Chief Medical Officer Neutral 52.5 - 0.00% ✗ -
Jan 3, 2022 Feb 11, 2022 Griffiths Graham Chief Business Officer Neutral 52.5 - 0.00% ✗ -
Jan 3, 2022 Feb 11, 2022 Evans Thomas George Chief Scientific Officer Neutral 52.5 - 0.00% ✗ -
Jan 3, 2022 Feb 11, 2022 Ellis Christopher COO Neutral 52.5 - 0.00% ✗ -
Jan 3, 2022 Feb 11, 2022 Enright William CEO Neutral 52.5 - 0.00% ✗ -
Jan 3, 2022 Feb 11, 2022 Egorov Georgy CFO Neutral 52.5 - 0.00% ✗ -
Dec 31, 2021 Jan 4, 2022 Hammacher Alex Director Buy 91.3 +1,000 100.00% ✗ $10.9K
Dec 22, 2021 Dec 23, 2021 Wright Robin Director Buy 95.0 +10,000 40.81% ✗ $99.7K
Nov 5, 2021 M&G Alternatives Investment Management Ltd 10% Owner Neutral 52.5 - 0.00% ✗ -
May 4, 2021 May 7, 2021 Enright William CEO Neutral 90.0 +514,923 69.26% ✗ -
May 4, 2021 May 6, 2021 DAWES KAREN A Director Buy 91.3 +1,700 100.00% ✗ $28.9K
May 4, 2021 May 6, 2021 Griffiths Graham Chief Business Officer Buy 90.0 +100 100.00% ✗ $1.7K
May 4, 2021 May 6, 2021 Wright Robin Director Buy 95.0 +14,000 133.26% ✗ $238K
May 4, 2021 May 6, 2021 Ellis Christopher COO Buy 90.0 +75 100.00% ✗ $1.3K
May 4, 2021 May 6, 2021 Scheeren Joseph Director Buy 95.0 +3,000 100.00% ✗ $51K
May 4, 2021 May 6, 2021 Phillips Anne M. Director Buy 95.0 +3,000 100.00% ✗ $51K
May 4, 2021 May 6, 2021 Oxford Sciences Innovation plc 10% Owner Buy 97.5 +600,000 7.32% ✗ $10.2M
Apr 29, 2021 May 4, 2021 Wright Robin Director Neutral 52.5 - 0.00% ✗ -
Apr 29, 2021 May 4, 2021 Scheeren Joseph Director Neutral 52.5 - 0.00% ✗ -
Apr 29, 2021 May 4, 2021 Phillips Anne M. Director Neutral 52.5 - 0.00% ✗ -
Apr 29, 2021 May 4, 2021 Morgon Pierre A. Director Neutral 52.5 - 0.00% ✗ -
Apr 29, 2021 May 4, 2021 Hammacher Alex Director Neutral 52.5 - 0.00% ✗ -
Apr 29, 2021 May 4, 2021 DAWES KAREN A Director Neutral 52.5 - 0.00% ✗ -
Apr 29, 2021 May 4, 2021 Enright William CEO Neutral 90.0 +455,775 61.31% ✗ -
Apr 29, 2021 May 4, 2021 Marshall Margaret Chief Medical Officer Neutral 52.5 - 0.00% ✗ -
Apr 29, 2021 May 4, 2021 Griffiths Graham Chief Business Officer Neutral 52.5 - 0.00% ✗ -
Apr 29, 2021 May 4, 2021 Evans Thomas George Chief Scientific Officer Neutral 52.5 - 0.00% ✗ -
Apr 29, 2021 May 4, 2021 Ellis Christopher COO Neutral 52.5 - 0.00% ✗ -
Apr 29, 2021 May 4, 2021 Egorov Georgy CFO Neutral 52.5 - 0.00% ✗ -
Apr 30, 2021 May 3, 2021 M&G INVESTMENT MANAGEMENT LTD 10% Owner Buy 100.0 +125,000 12.97% ✗ $1.8M
May 3, 2021 M&G INVESTMENT MANAGEMENT LTD 10% Owner Neutral 52.5 - 0.00% ✗ -
Apr 29, 2021 Oxford Sciences Innovation plc 10% Owner Neutral 52.5 - 0.00% ✗ -
Apr 29, 2021 Scheeren Joseph Director Neutral 52.5 - 0.00% ✗ -
Apr 29, 2021 Phillips Anne M. Director Neutral 52.5 - 0.00% ✗ -
Apr 29, 2021 Morgon Pierre A. Director Neutral 52.5 - 0.00% ✗ -
Apr 29, 2021 Marshall Margaret Chief Medical Officer Neutral 52.5 - 0.00% ✗ -
Apr 29, 2021 Hammacher Alex Director Neutral 52.5 - 0.00% ✗ -